News


As the NHS faces up to the unprecedented challenges posed by the threat of COVID-19, many other patients not affected by the coronavirus still rely on the services it provides for vital preventative care.  

As a company, Hart Biologicals is constantly championing the important role apprentices can play across departments throughout its organisation.  

As the impact of the current crisis widens around the world, Hart Biologicals continues a programme of stepping up to meet the challenge that the coronavirus poses. 

As the outbreak of the coronavirus COVID-19 makes a significant impact on the lives of everyone in the UK, Europe and in many parts of the world, Hart Biologicals is stepping up its efforts to ensure all customer needs and expectations are being met. 

At Hart Biologicals, we research and manufacture kits for the detection of blood and platelet disorders including that of systematic lupus erythematosus commonly known as Lupus or SLE. 

As the World Health Organisation labelled the outbreak of the coronavirus COVID-19 as a pandemic, the Hartlepool-based healthcare manufacturer has stepped up its campaign of vigilance to keep its customers and employees as safe as possible. 

 

Hart Biologicals has recently launched two new products in their MEA range to monitor and test the platelet response of patients. 

Two members of the Hart Biologicals QA team have attended the 3rd Annual European Medical Device and Diagnostic Quality Management Conference in Brussels.  

Self-experimentation in medical research has contributed to some of the biggest breakthroughs in medical history, as exampled by Marie Curie, Dr Jonas Silk, Dr Barry Marshall and others, whose incredible stories have paved the way to the create some of the medical science we use routinely today. 

The Quality Assurance department at Hart Biologicals covers a wide range of activities and is integral to the achievement of high standards and customer expectation. 

Looking forward to 2020

As 2019 draws to a close much has changed since the turn of the millennium in the pathology laboratory. 

Hart Biologicals attended the largest forum for medicine, Medica, on Wednesday November 20, in Düsseldorf, to discuss specialised haemostasis products and services with other companies in the industry.